Maternal coagulation inhibitors and the effects of cesarean delivery

B. B. Banias, T. E. Nolan, Lawrence D Devoe, J. S. Krauss

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Maternal hypercoagulability in normal pregnancy results from significant increases in blood factors that promote thrombosis or decreases in factors that inhibit thrombosis, such as antithrombin III (AT-III) and proteins C and S. The precise role of these factors in puerperal hemostasis is not clear. In 10 normal, pregnant women at term undergoing scheduled repeat cesarean section, the percent activities of AT-III, proteins C and S, and C4b-binding protein were determined in peripheral venous blood preoperatively and in samples of uterine venous blood before the uterine incision was made and 5 and 15 minutes after placental delivery using the Laurell Rocket electroimmunodiffusion technique. The mean percent activities of AT-III (73%), protein S (81%) and C4b-binding protein (85%) were lower than those in nonpregnant controls, were similar in peripheral and uterine venous blood and were unchanged after placental delivery. These data suggest that such factors may not play an important role in acute uteroplacental hemostasis during normal pregnancy.

Original languageEnglish (US)
Pages (from-to)741-744
Number of pages4
JournalJournal of Reproductive Medicine for the Obstetrician and Gynecologist
Volume37
Issue number8
StatePublished - Jan 1 1992

Fingerprint

Antithrombin III
Protein S
Complement C4b-Binding Protein
Mothers
Antithrombin Proteins
Protein C
Hemostasis
Thrombosis
Repeat Cesarean Section
Pregnancy
Thrombophilia
Pregnant Women

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Reproductive Medicine

Cite this

Maternal coagulation inhibitors and the effects of cesarean delivery. / Banias, B. B.; Nolan, T. E.; Devoe, Lawrence D; Krauss, J. S.

In: Journal of Reproductive Medicine for the Obstetrician and Gynecologist, Vol. 37, No. 8, 01.01.1992, p. 741-744.

Research output: Contribution to journalArticle

@article{2a7027b6ef41457baf374a1017a3f6d8,
title = "Maternal coagulation inhibitors and the effects of cesarean delivery",
abstract = "Maternal hypercoagulability in normal pregnancy results from significant increases in blood factors that promote thrombosis or decreases in factors that inhibit thrombosis, such as antithrombin III (AT-III) and proteins C and S. The precise role of these factors in puerperal hemostasis is not clear. In 10 normal, pregnant women at term undergoing scheduled repeat cesarean section, the percent activities of AT-III, proteins C and S, and C4b-binding protein were determined in peripheral venous blood preoperatively and in samples of uterine venous blood before the uterine incision was made and 5 and 15 minutes after placental delivery using the Laurell Rocket electroimmunodiffusion technique. The mean percent activities of AT-III (73{\%}), protein S (81{\%}) and C4b-binding protein (85{\%}) were lower than those in nonpregnant controls, were similar in peripheral and uterine venous blood and were unchanged after placental delivery. These data suggest that such factors may not play an important role in acute uteroplacental hemostasis during normal pregnancy.",
author = "Banias, {B. B.} and Nolan, {T. E.} and Devoe, {Lawrence D} and Krauss, {J. S.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "37",
pages = "741--744",
journal = "Journal of Reproductive Medicine",
issn = "0024-7758",
publisher = "Donna Kessel",
number = "8",

}

TY - JOUR

T1 - Maternal coagulation inhibitors and the effects of cesarean delivery

AU - Banias, B. B.

AU - Nolan, T. E.

AU - Devoe, Lawrence D

AU - Krauss, J. S.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Maternal hypercoagulability in normal pregnancy results from significant increases in blood factors that promote thrombosis or decreases in factors that inhibit thrombosis, such as antithrombin III (AT-III) and proteins C and S. The precise role of these factors in puerperal hemostasis is not clear. In 10 normal, pregnant women at term undergoing scheduled repeat cesarean section, the percent activities of AT-III, proteins C and S, and C4b-binding protein were determined in peripheral venous blood preoperatively and in samples of uterine venous blood before the uterine incision was made and 5 and 15 minutes after placental delivery using the Laurell Rocket electroimmunodiffusion technique. The mean percent activities of AT-III (73%), protein S (81%) and C4b-binding protein (85%) were lower than those in nonpregnant controls, were similar in peripheral and uterine venous blood and were unchanged after placental delivery. These data suggest that such factors may not play an important role in acute uteroplacental hemostasis during normal pregnancy.

AB - Maternal hypercoagulability in normal pregnancy results from significant increases in blood factors that promote thrombosis or decreases in factors that inhibit thrombosis, such as antithrombin III (AT-III) and proteins C and S. The precise role of these factors in puerperal hemostasis is not clear. In 10 normal, pregnant women at term undergoing scheduled repeat cesarean section, the percent activities of AT-III, proteins C and S, and C4b-binding protein were determined in peripheral venous blood preoperatively and in samples of uterine venous blood before the uterine incision was made and 5 and 15 minutes after placental delivery using the Laurell Rocket electroimmunodiffusion technique. The mean percent activities of AT-III (73%), protein S (81%) and C4b-binding protein (85%) were lower than those in nonpregnant controls, were similar in peripheral and uterine venous blood and were unchanged after placental delivery. These data suggest that such factors may not play an important role in acute uteroplacental hemostasis during normal pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0026672329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026672329&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 741

EP - 744

JO - Journal of Reproductive Medicine

JF - Journal of Reproductive Medicine

SN - 0024-7758

IS - 8

ER -